Background illustration for clinical trials search

Paid Clinical Trials Boulder

Discover 1,546 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,
Location: Aurora CO, Dallas TX, Rochester MN, Houston TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07223203

Phase 3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Aurora CO, Salt Lake City UT, Kansas City KS, Plano TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase 3, Recruiting

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

for
Epileptic Encephalopathy, SCN2A Encephalopathy
Location: Aurora CO, San Diego CA, Memphis TN, Chicago IL,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 0 - 18

Code: NCT07019922

Phase 3, Recruiting

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

for
Atypical Hemolytic-Uremic Syndrome
Location: Aurora CO, St Louis MO, Atlanta GA, London, Toronto,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT01522183

Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Aurora CO, Denver CO, Fort Collins CO,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

for
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Location: Englewood CO, Albuquerque NM, Wichita KS, Scottsdale AZ,
Sponsor: Lighthouse Pharmaceuticals, Inc.

Sex: All

Age: 55 - 70+

Code: NCT06847321

Phase 2, Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

for
Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,
Location: Englewood CO, Scottsdale AZ, Chandler AZ, Bolivar MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 55 - 70+

Code: NCT07589595

Phase 2, Recruiting

A Study of Buntanetap in Participants With PD

for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Englewood CO, Kansas City KS, Tulsa OK, Sun City AZ,
Sponsor: Annovis Bio Inc.

Sex: All

Age: 40 - 70+

Code: NCT07284784

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

for
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Location: Englewood CO, Scottsdale AZ, Rochester MN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 41 - 70+

Code: NCT07498426

Phase 3, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Englewood CO, Aurora CO, Scottsdale AZ, Dallas TX,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Denver CO, Aurora CO, Salt Lake City UT, Westwood KS,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase 3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Englewood CO, Aurora CO, Salt Lake City UT, Lubbock TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Englewood CO, Farmington NM, Lincoln NE, Wichita KS,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Englewood CO, Fort Worth TX, Los Angeles CA,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Englewood CO, Aurora CO, Salt Lake City UT, Murray UT,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase 3, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Englewood CO, Fairway KS, Tucson AZ, Dallas TX,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Englewood CO, Albuquerque NM, Sioux Falls SD,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

for
Advanced Solid Tumor,
Location: Denver CO, Tucson AZ, Cleveland OH, Washington D.C. DC,
Sponsor: Vaxiion Therapeutics

Sex: All

Age: 18+

Code: NCT05901285

Phase 1, Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for
Systemic Sclerosis Associated Interstitial Lung Disease,
Location: Aurora CO, El Paso TX, Scottsdale AZ, Tucson AZ,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05878717

Phase 2, Phase 3, Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for
Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma,
Location: Aurora CO, Sioux Falls SD, Fargo ND, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT02332668

Phase 1, Phase 2, Recruiting